ARF RHD Guidelines
The Guidelines were written by clinical and public health experts, researchers, and policymakers, and developed in collaboration with key stakeholders and an Aboriginal and Torres Strait Islander advisory group. They contain standards, recommendations, and guidance for providing clinically sound and culturally safe care to people living with acute rheumatic fever and rheumatic heart disease.
Emerging national and international evidence is reviewed regularly by relevant expert groups and the guidelines are updated as indicated. This document is no longer available in printed format.
Key Information
Key information extracted from each chapter in the RHDAustralia 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (3.2 edition, March 2022).
Tables and Figures
Important information extracted from 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (3.2 edition, March 2022).
- Medications for ARF
- Priority classifications of ARF and RHD and recommended follow up
- Referral algorithm for pregnant women with RHD
- Recommended duration of secondary prophylaxis
- Criteria for ARF diagnosis
- Priorities for managing ARF in acute setting
Guideline Implementation
The Guideline Implementation Plan highlights the activities, strategies, and responsibilities to implement the standards and recommendations in the 2020 Guideline and maintain a guideline that is current and relevant. It also includes the process used to review new and emerging evidence and make recommendation to the Guideline.